Activation of platelets exposed to shear stress in the presence of smoke extracts of low-nicotine and zero-nicotine cigarettes: The protective effect of nicotine

Nicotine and Tobacco Research

Volumn 6, Issue 5, 2004, Pages 835-841

  Ramachandran, Jaimohan ^a   Rubenstein, David ^a   Bluestein, Danny ^a   Jesty, Jolyon ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CIGARETTE SMOKE; NICOTINE;

ARTICLE; BLOOD FLOW; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOGENICITY;

ADULT; GANGLIONIC STIMULANTS; HUMANS; NICOTINE; PLATELET ACTIVATION; SHEAR STRENGTH; SMOKE; TOBACCO USE DISORDER;

EID: 8644263126     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220042000274284     Document Type: Article

References (14)

1. Benowitz, N. L., Fitzgerald, G. A., Wilson, M., & Zhang, Q. (1993). Nicotine effects on eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smoking. Journal of the American College of Cardiology, 22, 1159-1167.
2. Benowitz, N. L., & Gourlay, S. G. (1997). Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. Journal of the American College of Cardiology, 29, 1422-1431.
3. Blann, A. D., Steele, C., & McCollum, C. N. (1997). The influence of smoking and of oral and transdermal nicotine on blood pressure, and hematology and coagulation indices. Thrombosis and Haemostasis, 78, 1093-1096.
4. Fogarty, M. (2003). Can science make cigarettes safer? The Scientist, 17(6), 24.
5. Glantz, S. A., & Parmley, W. W. (1991). Passive smoking and heart disease: Epidemiology, physiology and biochemistry. Circulation, 83, 1-12.
6. Hioki, H., Aoki, N., Kawano, K., Homori, M., Hasumura, Y., Yasumura, T., Maki, A., Yoshino, H., Yanagisawa, A., & Ishikawa, K. (2001). Acute effects of cigarette smoking on platelet-dependent thrombin generation. European Heart Journal, 22, 56-61.
7. Jesty, J., & Bluestein, D. (1999). Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: Elimination of the feedback activation of platelet by thrombin. Analytical Biochemistry, 272, 64-70.
8. Jesty, J., Yin, W., Perrotta, P., & Bluestein, D. (2003). Platelet activation in a circulating flow loop: Combined effects of shear stress and exposure time. Platelets, 14, 143-149.
9. Kritz, H., & Sinzinger, H. (1996). Passive smoking, platelet function and atherosclerosis. Wien Klinisch Wochenschrift, 108, 582-588.
10. Ludviksdottir, D., Blondal, T., Franzon, M., Gudmundsson, T. V., & Sawe, U. (1999). Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. Journal of Internal Medicine, 246, 61-66.
11. Rubenstein, D., Jesty, J., & Bluestein, D. (2004). Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation, 109, 78-83.
12. Su, Y., Han, W., Giraldo, C., De Li, Y., & Block, E. R. (1998). Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. American Journal of Respiratory Cell and Molecular Biology, 19, 819-825.
13. U.S. Department of Health and Human Services. (2001, November 19). Risks associated with smoking cigarettes with low machine yields of tar and nicotine (Smoking and Tobacco Control Monograph No. 13). Retrieved April 13, 2004, from http://cancercontrol.cancer.gov/tcrb/monographs/13/m13_complete.pdf
14. Wennmalm, A., Benthin, G., Granström, E. F., Persson, L., Petersson, A. S., & Winell, S. (1991). Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation, 83, 1698-1704.